RE-implantation of CYpher stent for Cypher in-Lesion restenosis
Not Applicable
- Conditions
- ischemic heart disease
- Registration Number
- JPRN-UMIN000005038
- Lead Sponsor
- Coronary Intervention Trial & Evaluation (CITE) group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Post resuscitation Cardiogenic shock ST elevation myocardial infarction Unprotected Left main didesease Patients who cannot torelate anti-platelet therapy Pregnancy or lactation Patients who were enrolled in the other trials Malignancy No indication for PCI
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method late loss at 8-month follow-up angiography
- Secondary Outcome Measures
Name Time Method 1) restenosis rate 2) Target lesion revasclurarization at 8-month, 12-month 3) Major adverse cardiac events at 8-month, 12-month 4) stent thrombosis at 8-month, 12-month 5) impact of restenotic pattern such as fracture, gap, and edge restenosis on late loss